Earnings FeedTerminal

⌘K

Home/Filings/8-K/0001181431-05-000619

8-K//Current report

GENAERA CORP 8-K

Accession 0001181431-05-000619

CIK 0000880431operating

View on SEC.gov Company Profile

Filed

Jan 3, 7:00 PM ET

Accepted

Jan 4, 12:36 PM ET

Size

26.9 KB

Accession

0001181431-05-000619

Documents

2 files

8-K
rrd63476.htmPrimary
PILOT 2 PROGRAM
EX-99.1
rrd63476_2744.htm
PRESS RELEASE OF THE COMPANY DATED JANUARY 4, 2005 - "GENAERA ANNOUNCES SELECTION OF SQUALAMINE FOR AMD INTO FDA'S CONTINUOUS MARKETING APPLICATION PILOT 2 PROGRAM".

Issuer

GENAERA CORP

CIK 0000880431

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000880431

Filing Metadata

Form type: 8-K
Filed: Jan 3, 7:00 PM ET
Accepted: Jan 4, 12:36 PM ET
Size: 26.9 KB

View on SEC.gov